Anticipated Release Date: Q3FY26
ASPIRE will provide respiratory and ocular protection against Chemical, Biological, Radiological and Nuclear threats that allows near normal operations by minimizing or eliminating physical and psychological burden and increasing Warfighter lethality.
Responding to this opportunity requires membership in the Countering Weapons of Mass Destruction (CWMD) Consortium. This Consortium releases numerous solicitations throughout the year, so even if this opportunity may not end up being right for you, we strongly encourage you to join, so you are ready for the next opportunity.
Complete the form below and a program representative will reach out to you shortly to support you through the process.